Benzinga's Microcap Movers for Friday January 20, 2012
Below are highlights from Benzinga's daily coverage of microcap securities making big moves:
Shares of Proteonomix (PROT), the Mountainside, NJ biotechnology company, rose 31% Friday on almost 9 times the average daily volume.
Proteonomix was the subject of chat room and twitter discussion on Friday. There was no news associated with the price move. The company is developing treatments for a wide range of diseases using stem cells.
Proteonomix closed at $2.39 Friday.
Shares of Insmed, (NASDAQ: INSM), the Monmouth Junction, NJ biopharmaceutical company, rose 31% Friday on 26 times the average daily volume.
Insmed announced Friday that the U.S. Food and Drug Administration had lifted the clinical hold previously placed on ARIKACE in patients with non-tuberculous mycobacteria lung disease. Insmed continues to engage in discussions with FDA regarding the clinical hold placed on ARIKACE in Cystic Fibrosis patients with Pseudomonas lung infections.
The clinical holds placed on the ARIKACE programs in NTM and CF were based on an initial review by FDA of the results reported by Insmed of a long-term rat inhalation carcinogenicity study of ARIKACE.
Insmed Interactive closed at $5.01 Friday.
Shares of School Specialty (NASDAQ: SCHS), the Greenville, WI education company, rose 20% Friday on 4.5 times the average daily volume.
School Specialty announced Friday its 2012 expanded offering of classroom technology solutions. Meeting customers' continuously evolving technology needs, this comprehensive product assortment offers tools necessary to prepare students with 21st Century learning skills and augment traditional educational methods.
School Specialty closed at $2.93 Friday.
(c) 2013 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.